We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immunochromatographic Test Evaluated to Diagnose Schistosomiasis

By LabMedica International staff writers
Posted on 02 Feb 2016
The Kato-Katz (KK) stool smear is the standard test for the diagnosis of Schistosoma mansoni infection but suffers from low sensitivity when infections intensities are moderate to low and therefore, misdiagnosed individuals remain untreated and contribute to the disease transmission.

As an alternative, the urine-based diagnosis of schistosomiasis mansoni via the circulating cathodic antigen immuno-chromatographic test (CCA-ICT) has been extensively evaluated in Africa with the conclusion that it may replace the KK test in areas where the prevalence is moderate or high.

Scientists at the University Vale do Rio Doce (Governador Valadares, Brazil) and their colleagues measured the performance of the CCA-ICT in a sample study population composed of residents from non-endemic and endemic areas for schistosomiasis in two municipalities of Minas Gerais state (Brazil). More...
Volunteers were classified into three infection status groups based on duplicate Kato-Katz thick smears from one stool sample (2KK test): 41 negative individuals from non-endemic areas, 41 negative individuals from endemic areas and 48 infected individuals from endemic areas.

The rapid immuno-chromatographic test used was the commercially available Bilharzia RDT (Rapid Medical Diagnostics; Pretoria, Republic of South Africa), which measures a parasite-derived “circulating cathodic antigen (CCA)” in the urine of patients infected with S. mansoni. Infection status was also determined by the CCA-ICT and infection exposure by antibody enzyme-linked immunosorbent assay (ELISA) to S. mansoni soluble egg antigen (SEA) and soluble (adult) worm antigen preparation (SWAP).

The investigators found that sensitivity and specificity were influenced by whether the trace score visually adjudicated in the CCA-ICT was characterized as positive or negative for S. mansoni infection. When the trace score was interpreted as a positive rather than as a negative result, the specificity decreased from 97.6% to 78.0% whereas sensitivity increased from 68.7% to 85.4%. A significantly positive correlation between the CCA-ICT scores and egg counts was identified. Considering 2KK as reference test, the discriminating power of the CCA-ICT was greater than the SEA-ELISA and SWAP-ELISA.

The authors concluded that the performance of the CCA-ICT in the Brazilian communities endemic for schistosomiasis mansoni support those from Africa in areas with greater infection prevalence and intensities, the CCA-ICT may be useful as a tool to indicate community-based preventative chemotherapy without individual diagnosis. However, because of the Brazilian Ministry of Health’s recommendation for individual diagnosis in areas where prevalence is less than 15%, in those areas in which infection intensities are likely to be lowest, the CCA-ICT lacks the sensitivity to be used as standalone diagnostic tool. The study was published on January 11, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University Vale do Rio Doce 
Rapid Medical Diagnostics



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Candida Glabrata Test
ELIchrom Glabrata
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.